Therapy Areas: Oncology
Jazz Pharmaceuticals announces positive opinion from CHMP for Zanidatamab in HER2-positive biliary tract cancer
25 April 2025 - Biopharmaceutical company Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced on Friday that it has received a positive opinion from the European Medicines Agency's Committee for Me...
InnoCare receives NMPA approval for orelabrutinib as first-line treatment for CLL/SLL in China
25 April 2025 - Biopharmaceutical company InnoCare Pharma (HKEX: 09969) (SSE: 688428) announced on Friday that the China National Medical Products Administration (NMPA) has approved its BTK inhibitor,...
RaySearch Laboratories announces order from Odense University Hospital for RayStation
25 April 2025 - RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odens...
Guardant Health and Pfizer enter global collaboration to advance cancer therapy development
24 April 2025 - Precision oncology company Guardant Health Inc (Nasdaq:GH) said on Thursday that it has entered a multi-year global collaboration with biopharmaceutical company Pfizer Inc (NYSE:PFE) t...
Adcendo to present clinical stage ADC data at 2025 AACR Annual Meeting
24 April 2025 - Danish biotech company Adcendo ApS announced on Wednesday that it will be presenting data on its two novel antibody-drug conjugate (ADC) programs ADCE-T02, targeting Tissue Factor, and...
Tagworks Pharmaceuticals' TGW101 IND application granted FDA clearance for Phase 1 clinical trial
23 April 2025 - Tagworks Pharmaceuticals BV, a Netherlands-based clinical-stage precision oncology company, announced on Tuesday that the US Food and Drug Administration (FDA) has cleared its investig...